Red light therapy uses low-level light to influence cellular activity without relying on heat as its main effect. A common panel combines 660 nm red light with 850 nm near-infrared light. The 660 nm band is visible and may act more superficially; 850 nm is invisible and generally reaches deeper tissue.
Depth is not fixed, though. Skin tone, tissue thickness, distance, and device output all matter.
The wavelengths sit within ranges discussed in photobiomodulation research. A 2020 review by Dompe and colleagues in AIMS Biophysics describes commonly studied light between approximately 600 and 1,100 nm. The World Association for Photobiomodulation Therapy’s dose recommendations also stress delivered energy and treatment area, not wavelength alone.
In practice, irradiance, exposure time, and distance help determine the dose reaching skin. A wavelength label by itself tells only part of the story.
A 660/850 nm combination can therefore be understood as two light bands with different tissue interactions, not a guarantee of a particular result. Keep sessions consistent, follow the device’s safety instructions, and avoid staring into bright LEDs.
Small details count. Published findings vary by condition and protocol, and translating laboratory results into everyday use remains imperfect. That uncertainty deserves attention, not a confident promise.